402
Participants
Start Date
July 29, 2021
Primary Completion Date
March 25, 2024
Study Completion Date
May 1, 2024
TU-100
Treatment with investigational product
Placebo
Treatment with placebo product
New York Site, New York
Mineola Site, Mineola
Stony Brook Site, Stony Brook
Pittsburgh Site, Pittsburgh
Philadelphia Site #2, Philadelphia
Roanoke Site, Roanoke
Charleston Site, Charleston
Orlando Site, Orlando
Weston Site, Weston
Tampa Site, Tampa
Clearwater Site, Clearwater
Florence Site, Florence
Memphis Site, Memphis
Lexington Site, Lexington
Cleveland Site #2, Cleveland
Cleveland Site #1, Cleveland
Detroit Site, Detroit
Milwaukee Site, Milwaukee
Chicago Site #2, Chicago
Chicago Site #1, Chicago
Urbana Site, Urbana
St. Louis Site, St Louis
Metairie Site, Metairie
Little Rock Site, Little Rock
Dallas Site, Dallas
Fort Worth Site, Fort Worth
Salt Lake City Site, Salt Lake City
Gilbert Site, Gilbert
Los Angeles Site #1, Los Angeles
Los Angeles Site #2, Los Angeles
Duarte Site, Duarte
Palo Alto Site, Palo Alto
Sacramento Site, Sacramento
Danbury Site, Danbury
Boston Site #1, Boston
Newark Site, Newark
Tsumura USA
INDUSTRY